Workflow
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewswire News Room· 2025-05-14 20:01
Revenue for the First Quarter Ended March 31, 2025 was $13.1 million Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) Commercial Launch Off to a Strong Start, Initial Prescriptions Filled in Late March 2025 Phase 3 Clinical Trial Results for Emrosi Published in JAMA Dermatology Emrosi Now Included in Updated National Rosacea Society Treatment Algorithms Company to Hold Conference Call Today at 4:30 p.m. ET SCOTTSDALE, Ariz., May 14, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation ( ...
TMC Provides First Quarter 2025 Corporate Update
GlobeNewswire News Room· 2025-05-14 20:01
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), a leading explorer of the world’s largest undeveloped resource of critical metals essential to energy, defense, manufacturing, and infrastructure, today provided a corporate update and first quarter results for the period ending March 31, 2025. Q1 2025 Financial Highlights Total liquidity of approximately $43.8 million at March 31, 2025, including cash of $2.3 million ERAS/Barron facility increased ...
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire News Room· 2025-05-14 20:00
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or “the Company”) (NYSE: ELV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Elevance ...
Atrium Mortgage Investment Corporation Announces Election of Directors
Newsfile· 2025-05-14 20:00
Toronto, Ontario--(Newsfile Corp. - May 14, 2025) - Atrium Mortgage Investment Corporation (TSX: AI) (TSX: AI.DB.D) (TSX: AI.DB.F) (TSX: AI.DB.G) today announced that at its annual meeting of shareholders, held in Toronto earlier today, each of the eight director nominees listed in its management information circular dated March 25, 2025 was elected as a director. Directors have been elected to serve until the close of the next annual meeting of shareholders. The detailed results of the vote for the electi ...
Red Cat Reports Financial Results for First Quarter 2025 and Provides Corporate Update
GlobeNewswire News Room· 2025-05-14 20:00
SAN JUAN, Puerto Rico, May 14, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) ("Red Cat" or the "Company"), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, reports its financial results for the first quarter ended March 31, 2025 and provides a corporate update. Recent Operational Highlights Announced the expansion of our multi-domain Family of Systems with a new line of Unmanned Surface Vessels (USVs). This strategic m ...
Roche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with Emrelis
GlobeNewswire News Room· 2025-05-14 20:00
The VENTANA MET (SP44) RxDx Assay detects the MET (also known as c-Met) protein, which is over-expressed in some patients with non-squamous non-small cell lung cancer (NSQ-NSCLC).The MET protein serves as a predictive biomarker for the likelihood of a patient’s response to c-Met-targeted therapy.1As the leader in companion diagnostics, Roche’s broad CDx portfolio helps enable informed clinical decisions and improved patient outcomes. Basel, 14 May 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today th ...
Waymo recalls 1,200 robotaxis following low-speed collisions with gates and chains
TechCrunch· 2025-05-14 19:57
Core Points - Waymo issued a software recall for 1,200 self-driving vehicles due to minor collisions with gates and similar objects [1] - The recall was initiated to comply with regulatory reporting obligations after NHTSA's preliminary evaluation of Waymo's automated driving system [2] - Waymo's fleet has grown to 1,500 commercial robotaxis operating in major cities, following a software update that reduced collision likelihood [3] Regulatory and Safety Evaluation - NHTSA opened an evaluation after seven incidents of collisions with stationary objects were reported between December 2022 and April 2024, with no injuries [2] - Ongoing discussions between Waymo and NHTSA focused on the comparative risk of autonomous vehicles, with additional collision data provided [4] Previous Recalls - Waymo has previously issued recalls, including one in June 2024 for Jaguar I-Pace robotaxis after a collision with a telephone pole, and another in February 2024 after two robotaxis crashed into a towed pickup truck [5]
smartShift Revolutionizes SAP Modernization with AI-Powered Revert to Standard
GlobeNewswire News Room· 2025-05-14 19:55
Boston, MA, May 14, 2025 (GLOBE NEWSWIRE) -- smartShift, a global leader in SAP custom code transformation, today announced the development of a groundbreaking AI-powered solution designed to help SAP customers accelerate their transition to a Clean Core. This innovation empowers organizations to systematically identify and replace custom ABAP code with standard SAP functionality, streamlining operations and preparing for SAP S/4HANA and RISE with SAP. As enterprises seek to simplify their ERP environments, ...
Visa Inc. (V) CEO Ryan McInerney Presents at Annual JPMorgan Global Technology, Media and Communications Conference (Transcript)
Seeking Alpha· 2025-05-14 19:51
Visa Inc. (NYSE:V) Annual JPMorgan Global Technology, Media and Communications Conference May 14, 2025 12:20 PM ET Company Participants Ryan McInerney - CEO Conference Call Participants Tien-Tsin Huang - JP Morgan Tien-Tsin Huang All right, I think we're going to get started here. We'll let everyone continue eating their lunch. My name is Tien-Tsin Huang. I follow the payments and IT services sector at J.P. Morgan. And this is the lunch keynote with Visa. Always delighted to have Visa. And someone that I re ...
Nutex Health Inc. (NUTX) Q1 2025 Earnings Conference Call Transcript
Seeking Alpha· 2025-05-14 19:51
Nutex Health Inc. (NASDAQ:NUTX) Q1 2025 Earnings Conference Call May 14, 2025 10:30 AM ET Company Participants Jennifer Rodriguez - IR Manager Tom Vo - Chairman and CEO Jon Bates - CFO Warren Hosseinion - President Josh DeTillio - COO Conference Call Participants Bill Sutherland - The Benchmark Company Thomas McGovern - Maxim Group Gene Mannheimer - Freedom Capital Markets Joshua Cohen - Westbury Capital Operator Greetings. Welcome to Nutex Health's First Quarter 2025 Financial Results Conference Call. At t ...